XML 21 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Cash Equivalents and Marketable Securities
3 Months Ended
Mar. 31, 2017
Investments Debt And Equity Securities [Abstract]  
Cash Equivalents and Marketable Securities

3. Cash Equivalents and Marketable Securities

The following tables summarize the estimated fair value of the Company’s cash equivalents and marketable securities and the gross unrealized gains and losses (in thousands):

 

 

 

March 31, 2017

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Estimated

Fair Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

3,781

 

 

$

 

 

$

 

 

$

3,781

 

Reverse repurchase agreements

 

 

10,250

 

 

 

 

 

 

 

 

 

10,250

 

Total cash equivalents

 

 

14,031

 

 

 

 

 

 

 

 

 

14,031

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US government and agency securities

 

 

41,104

 

 

 

 

 

 

(37

)

 

 

41,067

 

Total marketable securities

 

$

41,104

 

 

$

 

 

$

(37

)

 

$

41,067

 

 

 

 

December 31, 2016

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Estimated

Fair Value

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

4,584

 

 

$

 

 

$

 

 

$

4,584

 

Reverse repurchase agreements

 

 

39,250

 

 

 

 

 

 

 

 

 

39,250

 

Total cash equivalents

 

 

43,834

 

 

 

 

 

 

 

 

 

43,834

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

US government and agency securities

 

 

15,758

 

 

 

 

 

 

(4

)

 

 

15,754

 

Total marketable securities

 

$

15,758

 

 

$

 

 

$

(4

)

 

$

15,754

 

 

The reverse repurchase agreements are settled in cash nightly, and as such are classified as cash equivalents.

As of March 31, 2017 and December 31, 2016, the Company held 22 and nine debt securities, respectively, that were in an unrealized loss position for less than one year. The aggregate fair value of debt securities in an unrealized loss position as of March 31, 2017 and December 31, 2016 were $41.1 million and $15.8 million, respectively, with no individual securities in a significant unrealized loss position. The Company evaluated its securities for other-than-temporary impairment and considered the decline in market value for the securities to be primarily attributable to current economic and market conditions and would not be required to sell the securities before recovery of the amortized cost basis. Based on this analysis, these marketable securities were not considered to be other-than-temporarily impaired as of March 31, 2017 and December 31, 2016.

The following tables summarizes the contractual maturities of the Company’s marketable securities at estimated fair value (in thousands):

 

 

 

March 31,

 

 

December 31,

 

 

 

2017

 

 

2016

 

Due in one year or less

 

$

39,075

 

 

$

15,754

 

Due in 1 - 2 years

 

 

1,992

 

 

 

 

Total marketable securities

 

$

41,067

 

 

$

15,754

 

 

The Company may sell investments at any time for use in current operations even if they have not yet reached maturity. As a result, the Company classifies marketable securities, including securities with maturities beyond twelve months as current assets.